Viewpoint: Reinforcing the OD’s Importance

What do type 2 diabetes and weight loss drugs have to do with the annual Practicing Medical Optometry Diabetes issue?

By: Jennifer Kirby, managing editor

Optometric Management May 1, 2025 Vol 60(4), Issue May 2025 Page(s): 2

5 Key Takeaways

1

GLP-1 agonists are effective in managing type 2 diabetes and obesity, with 8-10% of Americans currently using them.
2

A study links GLP-1 agonists to worsening diabetic retinopathy, highlighting the need for careful monitoring.
3

Optometrists play a crucial role in managing diabetic retinopathy, utilizing advanced technologies for patient care.
4

The article encourages optometrists to inform local healthcare providers about the risks associated with GLP-1 agonists.
5

Additional topics include ocular nutritional supplements for diabetic retinopathy and coding for diabetes management.

Sarah Fackler

Affiliations: Ophthalmology Management

Specialties: Ophthalmology

Bio: Sarah Fackler writes for Ophthalmology Management and Optometric Management, covering topics relevant to ophthalmology practices and the eye care workforce. Her reporting includes coverage of the 2025 American Academy of Ophthalmology Annual Meeting, including practice management strategies for retaining and attracting qualified team members.

managing editor

Managing Editor

Affiliations: Optometric Management

Bio: Sarah Fackler serves as managing editor at Optometric Management. In this role, she writes and edits coverage for the publication, including reporting on clinical updates in optometry such as new medications for dry eye disease and presbyopia presented at major meetings including SECO.

PentaVision

Optometric Management

Viewpoint: Reinforcing the OD’s Importance

5 Key Takeaways

1

2

3

4

5

Recommendations